CLINICAL_TRIALS
trial_result
· 2013-06-21
Clinical Trial Update: A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g [Phase 3]
Summary
Phase 3 trial update for Raptiva (efalizumab) in adults with psoriasis, focusing on plaque psoriasis, with the study having completed enrollment.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genentech, Inc. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED